A recent clinical evaluation study on small number of AAA patients (n = 11) showed that selective activation of vitamin D receptor (VDR) by paricalcitol (1 μg daily, 24–weeks before open AAA repair) interferes with calcineurin-mediated inflammation in AAA [51]. The gene discussed is VDR; the disease is triple-A syndrome.